1. Clarifications on oxycodone–naloxone combination in cancer pain management

   • Sebastiano Mercadante

   Letter to the Editor 14 April 2012 Pages: 1351 - 1352

2. Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients

   • George Dranitsaris
   • Eleftheria Hatzimichael

   Review Article Open access 27 April 2012 Pages: 1353 - 1360

3. An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors

   • Yin Ting Cheung
   • Earl Hsien-Jie Tan
   • Alexandre Chan

   Review Article 05 April 2012 Pages: 1361 - 1375

   

4. A systematic review of unmet needs of newly diagnosed older cancer patients undergoing active cancer treatment

   • M. T. E. Puts
   • A. Papoutsis
   • A. E. Tourangeau

   Review Article 04 April 2012 Pages: 1377 - 1394

   

5. Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm

   • Z. Reguiai
   • J. B. Bachet
   • O. Bouché

   Review Article 27 April 2012 Pages: 1395 - 1404

6. Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients

   • Brian D. Hodgson
   • David M. Margolis
   • Harry T. Whelan

   Original Article 03 July 2011 Pages: 1405 - 1415

   

7. Nutritional and psychosocial status of colorectal cancer patients referred to an outpatient oncology clinic

   • Helena Maria Lizardo Daudt
   • Cheri Cosby
   • Rubayed Nurullah

   Original Article 07 July 2011 Pages: 1417 - 1423

8. Acute stress in patients with brain cancer during primary care

   • Simone Goebel
   • Hans Strenge
   • H. Maximilian Mehdorn

   Original Article 30 June 2011 Pages: 1425 - 1434

9. Electrocardiographic findings of palonosetron in cancer patients

   • Guzin Gonullu
   • Sabri Demircan
   • Idris Yucel

   Original Article 20 July 2011 Pages: 1435 - 1439

10. Examining the role of physical activity in reducing postcancer fatigue

    • Marieke F. M. Gielissen
    • Jan F. Wiborg
    • Gijs Bleijenberg

    Original Article Open access 21 July 2011 Pages: 1441 - 1447

    

11. Mismatch of desired versus perceived social support and associated levels of anxiety and depression in newly diagnosed cancer patients

    • Wolfgang Linden
    • Andrea Vodermaier

    Original Article 09 July 2011 Pages: 1449 - 1456

    

12. Physician endorsement alone may not enhance question-asking by advanced cancer patients during consultations about palliative care

    • Josephine M. Clayton
    • Christine Natalia
    • Martin H. N. Tattersall

    Original Article 26 July 2011 Pages: 1457 - 1464

    

13. Caregivers’ morbidity in palliative care unit: predicting by gender, age, burden and self-esteem

    • Gema Costa-Requena
    • Ramon Cristófol
    • José Cañete

    Original Article 04 August 2011 Pages: 1465 - 1470

14. Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study

    • Paul J. Hesketh
    • Oliver Wright
    • Anatoly Makhson

    Original Article 07 August 2011 Pages: 1471 - 1478

    

15. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients

    • Julie L. Ryan
    • Charles E. Heckler
    • Gary R. Morrow

    Original Article 05 August 2011 Pages: 1479 - 1489

    

16. Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study

    • Ya-Hsu Yang
    • Jen-Kou Lin
    • Hao-Wei Teng

    Original Article 04 August 2011 Pages: 1491 - 1497

17. Cluster of symptoms in women with breast cancer treated with curative intent

    • Alexandre Lopes Evangelista
    • Erika Maria Monteiro Santos

    Original Article 16 August 2011 Pages: 1499 - 1506

18. A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy

    • Kenjiro Aogi
    • Hiroshi Sakai
    • Noriyuki Masuda

    Original Article 02 August 2011 Pages: 1507 - 1514

    

19. Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study

    • Isabella Uzaraga
    • Bev Gerbis
    • Elaine Wai

    Original Article 17 August 2011 Pages: 1515 - 1524

    

20. Incidence of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy

    • Alexandre Chan
    • Christy Chen
    • Raymond Ng

    Original Article 05 August 2011 Pages: 1525 - 1532

21. Psychotropic medication during endocrine treatment for breast cancer

    • Geertruida H. de Bock
    • Regina F. Musters
    • Lolkje T. W. de Jong-van den Berg

    Original Article Open access 06 August 2011 Pages: 1533 - 1540

    

22. Inpatient oncology rehabilitation in Toronto: a descriptive 18-month retrospective record review

    • Sara E. McEwen
    • Sarah Elmi
    • Mila Bishev

    Original Article 05 August 2011 Pages: 1541 - 1547

23. Decrease in the vinorelbine-induced venous irritation by pharmaceutical intervention

    • Takaaki Yamada
    • Nobuaki Egashira
    • Ryozo Oishi

    Original Article 31 July 2011 Pages: 1549 - 1553

    

24. Development and validation of the simplified Chinese version of EORTC QLQ-H&N35 for patients with head and neck cancer

    • Zheng Yang
    • Qiong Meng
    • Chonghua Wan

    Original Article 18 August 2011 Pages: 1555 - 1564

25. A pilot study of adrenal suppression after dexamethasone therapy as an antiemetic in cancer patients

    • Hye-Suk Han
    • Young Kwang Shim
    • Seung Taik Kim

    Original Article 18 August 2011 Pages: 1565 - 1572

    

26. Enhancing patient-reported outcome measurement in research and practice of palliative and end-of-life care

    • Steffen T. Simon
    • Irene J. Higginson
    • on behalf of PRISMA

    Short Communication 07 March 2012 Pages: 1573 - 1578

27. The use of cancer treatment summaries and care plans among Massachusetts physicians

    • Anna Merport
    • Stephenie C. Lemon
    • Marianne N. Prout

    Short Communication 14 April 2012 Pages: 1579 - 1583

28. Lenalidomide cutaneous adverse event: a case of Stevens–Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone

    • A. Siniscalchi
    • A. Tendas
    • T. Caravita

    Short Communication 05 May 2012 Pages: 1585 - 1587